About Diamyd Medical
Diamyd Medical develops the diabetes vaccine Diamyd®, an antigen-specific immunotherapy based on the exclusively licensed GAD-molecule. GABA constitutes alongside with the diabetes vaccine a key asset in Diamyd Medical and the Company uses its GABA in-licensed technology to develop a proprietary GABA drug product.
Diamyd Medical’s shares are traded on Nasdaq Stockholm First North, ticker DMYD B.
Diamyd Medical develops the diabetes vaccine Diamyd®, an antigen-specific immunotherapy based on the exclusively licensed GAD-molecule. GABA constitutes alongside with the diabetes vaccine a key asset in Diamyd Medical and the Company uses its GABA in-licensed technology to develop a proprietary GABA drug product. Diamyd Medical’s shares are traded on Nasdaq Stockholm First North, ticker DMYD B.
Company Highlights
Year Founded
1994
Employees
40
Location (HQ)
SWE
Since Last Funding
4 months
Monthly Website Visitors
11.4K
Total Investment Amt
$16M
Last Funding Round
Post Ipo Equity
MoM Headcount Growth
-2.43%
YoY Headcount Growth
2.56%
Key Metrics
Senior Hires
Name | Linkedin Profile | Position | Date Joined |
---|---|---|---|
John Doe | https://www.linkedin.com/in/johndoe | CEO | CEO |
Jane Doe | https://www.linkedin.com/in/janedoe | CTO | CTO |
John Smith | https://www.linkedin.com/in/johnsmith | CFO | CFO |
Jane Smith | https://www.linkedin.com/in/janesmith | COO | COO |
Biotechnology
- LipUmSprint BioscienceCellevateCaptarioCantargiaAlba HealthXintela AB (publ)ANYO LabsMolecular AttractionBrighterCombiGeneElyptaAnaCardioPIxelgen TechnologiesNEOGAP TherapeuticsAsgard TherapeuticsCountagenAcarixGAIA BioMaterialsSenzaGen ABCellectriconSigrid TherapeuticsInDex PharmaceuticalsEmpe DiagnosticsIlya PharmaImmunicumBioReperiaInhalation SciencesIn Singulo SolutionsUmecrine CognitionGedea BiotechCavidiAbliva ABVerigraft ABOncorenaImmuneedOblique TherapeuticsIndustrifondenZelmic ABWatersprintNavinci DiagnosticsAscelia PharmaElsa Science ABNovAbCardiaBiopetroliaStrike Pharma ABFluicellAtley SolutionsClinical Laserthermia SystemsScandinavian BiopharmaRarity BioscienceAplex BioScandinavian Real HeartsCarbiotixMycorenaUmeå Biotech IncubatorPharmacolog I Uppsala AbBioservo TechnologiesPixelgen Technologies1928 DiagnosticsImmunoviaScietyCinclus PharmaAddLife ABPEPTONIC medical ABSingle TechnologiesVicore PharmaSymcelGradientechBPC InstrumentsPromimicMedivirPhase Holographic ImagingSpinChemGenovisNextCell Pharma ABActive Biotech ABIntervaccBioStock - Connecting Innovation and Capital
Pharmaceutical Manufacturing
- Sprint BioscienceAlzeCure PharmaBeactica Therapeutics ABOnDosisAnaCardioNEOGAP TherapeuticsGesynta PharmaDisruptive Pharma ABMoberg DermaInDex PharmaceuticalsIlya PharmaCORLINE BIOMEDICAL ABAbliva ABOncorenaOblique TherapeuticsZelmic ABAscelia PharmaScandinavian BiopharmaXNK TherapeuticsEgetis Therapeutics ABNewbury PharmaceuticalsCinclus PharmaVicore PharmaMedivirToleranzia ABIconovoIntervaccAlzeCure Pharma AB